7 completed, 1 terminated. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Terminated 1 |
Follow ferric maltol: new trials by email Literature Review of ferric maltol trials Research Report on ferric maltol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Iron for Colorectal Cancer (PICoC Study) oral ferric maltol - Cancer Colon | Phase 3 | Completed | The Royal Wolverhampton Hospitals NHS Trust | 40 | 2022-05-30 | 2026-01-30 |
| Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years Ferric Maltol, Ferrous sulfate - Anemia, Iron-deficiency | Phase 3 | Completed | Shield Therapeutics | 65 | 2021-11-03 | 2025-11-10 |
| Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease Ferric Maltol, Placebo Oral Capsule - Iron Deficiency Anaemia | Phase 3 | Completed | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 122 | 2021-09-01 | 2026-07-31 |
| ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1) Ferric maltol 30 mg (Feraccru®) - Hypertension, Pulmonary, Anemia, Iron Deficiency | Phase 3 | Terminated | Hannover Medical School | 22 | 2018-03-27 | 2020-04-21 |
| Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease Ferric maltol, Placebo - Renal Insufficiency, Chronic, Iron-Deficiency Anemia | Phase 3 | Completed | Shield Therapeutics | 167 | 2016-12-01 | 2020-11-02 |
| Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD Ferric Maltol, Ferric Carboxy Maltose - Anemia, Iron-Deficiency, Inflammatory Bowel Disease | Phase 3 | Completed | Shield Therapeutics | 250 | 2016-01-01 | 2020-11-02 |
| Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) ST10, Placebo oral capsule - Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase 3 | Completed | Shield Therapeutics | 128 | 2011-08-01 | 2020-10-30 |
| Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) ST10-021, Placebo Comparator - Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase 3 | Completed | Shield Therapeutics | 128 | 2011-08-01 | 2020-10-30 |
Anemia, Iron-Deficiency (7) · Anemia (4) · Iron Deficiencies (4) · Inflammatory Bowel Diseases (3) · Crohn Disease (2) · Colitis, Ulcerative (1) · Colonic Neoplasms (1) · Deficiency Diseases (1) · Hypertension, Pulmonary (1) · Intestinal Diseases (1) · Renal Insufficiency, Chronic (1)
Shield Therapeutics (5) · Hannover Medical School (1) · Jiangsu Aosaikang Pharmaceutical Co., Ltd. (1) · The Royal Wolverhampton Hospitals NHS Trust (1)
United States (3) · Germany (2) · United Kingdom (2) · Belgium (1) · China (1) · France (1) · Hungary (1) · Puerto Rico (1) · Spain (1)
Nicholas Mallard, PhD (2) · Jackie Mitchell, PhD (1) · Marius Hoeper, Prof. Dr. (1) · Mark Sampson, MBChB (1) · Nuha Yassin (1)